Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer

Michael J. Baine, Vivek Verma, Caitlin A. Schonewolf, Chi Lin, Charles B. Simone

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Background: Contrary to prevailing notions of uniform efficacy regarding stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC), a recent report has indicated increased risk of local failure for squamous cell carcinoma (SCC). As those data have not been corroborated by other studies, we performed a multi-institutional analysis to evaluate the influence of histology on post-SBRT outcomes. Materials and methods: Records from 152 consecutive patients who received SBRT for primary early-stage NSCLC at two academic medical centers were retrospectively assessed. Primary comparison was between SCC and adenocarcinoma. Patient outcomes including actuarial recurrences and overall survival were calculated using the Kaplan-Meier method. Univariable and multivariable logistic regression analyses addressed associated factors. Results: At a median follow-up of 44 months, patients with SCC had an increased risk of local, (hazard ratio (HR) (95% confidence interval (CI)): 1.69 (1.05–2.73), p = 0.032), regional (HR (95% CI): 2.03 (1.24–3.33), p = 0.005), and distant failure (HR (95% CI): 1.71 (1.06–2.77), p = 0.036). Median times to local (32 m vs 50m, p = 0.023), regional (26 m vs 50 m, p = 0.011), and distant (26 m vs 50 m, p = 0.024) failure were all significantly reduced in SCC histology. SCC histology was also independently associated with an increased risk for death (HR: 1.80 (1.10–2.94), p = 0.019) and had a 5-yr overall survival of 26%, versus 41% for adenocarcinoma (p = 0.016). Conclusions: This multi-institutional analysis corroborates that SCC histology is independently predictive for local, regional, and distant recurrence and worse overall survival. Future data are needed to determine if treatment paradigms should differ by histology for early stage NSCLC.

Original languageEnglish (US)
Pages (from-to)20-26
Number of pages7
JournalLung Cancer
StatePublished - Apr 2018


  • Histology
  • Non-small cell lung cancer
  • Squamous cell carcinoma
  • Stereotactic body radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this